Back to Screener

Healthcare

BioDelivery Sciences Intl, Inc. Wrrt(BDSIW)

Live Price

Offline

$0.04

-25.00% today

1Y Change

—

Window

No data

Market Cap
—
Revenue Growth
+6.5%
EPS Growth
+215.4%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BioDelivery Sciences Intl, Inc. Wrrt (BDSIW) is a Healthcare stock. The stock last traded around $0.04. Baseline metrics include revenue growth of +6.5%, EPS growth of +215.4%, a dividend yield of 0.0%. What stands out right now is revenue +6.5%, EPS +215.4%, free cash flow +62.7% with operating margin 22.3% and ROIC 15.0%. Valuation is more restrained than many high-expectation growth names at P/E 6.8 and price/sales 3.5. Stock Foundry combines BDSIW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Near sector median

+6.5% vs +7.6% peer median

Operating Margin

Above sector median

+22.3% vs +19.4% peer median

P/E

Below sector median

6.8 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report came in below the EPS bar

2020 was reported on Mar 31, 2020 with an EPS surprise of -23.9% and a revenue surprise of -6.7%.

The operating story is still moving forward

Revenue is running at +6.5% and EPS at +215.4%, with operating margin around 22.3%.

Benchmark Edge

BDSIW vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BDSIW

—

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BDSIW Max Drawdown

—

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BDSIW and SPY.

Calendar-year return history is still loading or unavailable.
BI

Company Overview

BioDelivery Sciences Intl, Inc. Wrrt

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
6.8
EV/EBITDA
11.7
Price/Sales
3.5
Price/Book
3.1

Growth

Revenue
+6.5%
EPS
+215.4%
Free Cash Flow
+62.7%

Profitability

Gross Margin
86.0%
Operating Margin
22.3%
Net Margin
50.9%
ROE
57.3%
ROIC
15.0%

Balance Sheet

Debt/Equity
0.31
Current Ratio
2.45

Earnings Reports

📅 Last reportedMar 31, 2020
PeriodB/MEPSEPS ΔRevenueRev Δ
—
Mar 31, 20
✗
0.05
Est 0.06
-23.9%
37715.0B
Est 40439.7B
-6.7%
—
Dec 31, 19
✓
-0.01
Est -0.01
+24.8%
30450.0B
Est 30466.9B
-0.1%
—
Sep 30, 19
✗
0.00
Est 0.00
-2.0%
27992.0B
Est 27987.5B
+0.0%
—
Jun 30, 19
✓
-0.14
Est -0.15
+7.2%
29677.0B
Est 23799.0B
+24.7%
—
Mar 31, 19
✗
-0.05
Est -0.04
-16.5%
19769.0B
Est 18820.1B
+5.0%
—
Dec 31, 18
✓
-0.11
Est -0.11
+1.3%
18029.0B
Est 17400.5B
+3.6%
—
Sep 30, 18
✓
-0.11
Est -0.15
+31.5%
14155.0B
Est 16429.4B
-13.8%
—
Jun 30, 18
✗
-0.17
Est -0.14
-19.2%
12175.0B
Est 15618.0B
-22.1%
—
Mar 31, 18
✗
-0.18
Est -0.13
-35.8%
11281.0B
Est 13365.4B
-15.6%
—
Dec 31, 17
✓
-0.29
Est -0.42
+30.8%
12512.0B
Est 5747.8B
+117.7%
—
Sep 30, 17
✓
-0.21
Est -0.25
+14.7%
11253.0B
Est 4636.9B
+142.7%
—
Jun 30, 17
✓
0.31
Est 0.27
+15.9%
8742.0B
Est 15396.0B
-43.2%
—
Mar 31, 17
✗
0.87
Est 1.22
-28.5%
29478.0B
Est 10218.6B
+188.5%
—
Dec 31, 16
✓
-0.30
Est -0.40
+25.0%
3931.0B
Est -4102.4B
+195.8%
—
Sep 30, 16
✓
-0.30
Est -0.40
+26.1%
3571.0B
Est 3543.9B
+0.8%
—
Jun 30, 16
✗
-0.31
Est -0.18
-75.7%
5004.0B
Est 3407.2B
+46.9%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks